PTP4A1/PRL1 antibody 11508-1-AP from Proteintech Group Inc

Product Specs
ItemPTP4A1/PRL1 antibody
CompanyProteintech Group Inc
Price Pricing Info Supplier Page View Company Product Page
Catalog Number11508-1-AP
Conjugate/TagUnconjugated
ApplicationsWB, IHC, ELISA
Quantity20ul
ReactivityHuman, Mouse
IsotypeIgG
FormatPBS with 0.02% sodium azide and 50% glycerol pH 7.3
HostRabbit
ClonalityPolyclonal
Antibody Typeprimary antibodies
PurityAntigen affinity purification
ImmunogenRecombinant Protein
NCBI Full Gene Nameprotein tyrosine phosphatase 4A1
NCBI Gene AliasesHH72, PRL-1, PRL1, PTP(CAAX1), PTPCAAX1
Research AreaCell Cycle, Cytoskeleton/Scaffold Proteins, Development, Membrane Proteins, Metabolism
TargetPTP4A1/PRL1

Specifications/Features

20ul available

Add to Compare List

Proteintech Group Inc

5500 Pearl Street, Suite 400

Rosemont,, Illinois 60018

United States

Phone: 1-888-478-4522

Email: proteintech@ptglab.com

Company Profile

Website: http://www.ptglab.com

(1) ERα inhibits mesenchymal and amoeboidal movement of liver cancer cell via Gα12International journal of cancerMay 15, 2022Yun J, Kim YS, Heo MJ, Kim MJ, Moon A, Kim SG.

(2) RP5-1148A21.3 (lncRP5) exerts oncogenic function in human ovarian carcinomaActa Biochimica et Biophysica SinicaFebruary 25, 2022Pingping Sun, Aimei Bao, Xiangdong Hua, Jian Cao, Ye Dingblocked the membranes were incubated with the indicated primary antibodies: anti-PTP4A1 antibody (1:600, 11508-1-AP; Proteintech, Chicago, USA) and anti-GAPDH antibody (1:5000, ab8245; Abcam) at 4°C overnight. After

(3) The adaptor SH2B1 and the phosphatase PTP4A1 regulate the phosphorylation of cytohesin-2 in myelinating Schwann cells in miceScience signalingJanuary 25, 2022Miyamoto Y, Torii T, Homma K, Oizumi H, Ohbuchi K, Mizoguchi K, Takashima S, Yamauchi J.

(4) MicroRNA-1271 functions as a metastasis and epithelial-mesenchymal transition inhibitor in human HCC by targeting the PTP4A1/c-Src axisInternational journal of oncologyFebruary 1, 2018Li C, Jiang Y, Miao R, Qu K, Zhang J, Liu C.1:1,000 dilution overnight at 4˚C. The purchased primary antibodies were listed as follows: PTP4A1 (11508-1-AP) and N-cadherin (22018-1-AP) from Proteintech Group, Inc. (Rosemont, IL, USA); N-cadherin (#3195), vimentin

(5) Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1OncotargetMay 31, 2016Voena C, Varesio LM, Zhang L, Menotti M, Poggio T, Panizza E, Wang Q, Minero VG, Fagoonee S, Compagno M, et al.

(6) miR-339-3p inhibits proliferation and metastasis of colorectal cancerOncology lettersNovember 1, 2015Zhou C, Lu Y, Li X.

(7) MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1PloS oneJanuary 1, 2013Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng L, Chen F, Peng F, Li X.